Le Lézard
Classified in: Covid-19 virus
Subject: ANNUAL MEETINGS

Orocobre Limited 2021 Annual General Meeting Information


BRISBANE, Australia, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Orocobre Limited (ASX: ORE, TSX: ORL) (Orocobre or the Company), advises that its 2021 Annual General Meeting (AGM) will be held at 11.00am AEST on Tuesday 30 November 2021. In the interests of safety for shareholders, employees and the broader community during the COVID-19 pandemic, the 2021 AGM will be held virtually, rather than at a physical location.

Shareholders will be provided with information on how to participate in the AGM when the Notice of Meeting is released this month. The Notice of Meeting will also be available on the ASX Company Announcements Platform and Orocobre's website at: https://www.orocobre.com.

The closing time for receipt of director nominations for any candidates other than those recommended by the Board is 5.00pm AEST, Tuesday 19 October 2021.

This announcement has been approved by:

Rick Anthon
Joint Company Secretary

For more information please contact:

Andrew Barber
Chief Investor Relations Officer
Orocobre Limited
T: +61 7 3720 9088
M: +61 418 783 701
E: [email protected]
W: www.orocobre.com

Twitter: https://twitter.com/OrocobreLimited
LinkedIn: https://www.linkedin.com/company/orocobre-limited
Facebook: https://www.facebook.com/OrocobreLimited/
Instagram: https://www.instagram.com/orocobre/
YouTube: https://www.youtube.com/OrocobreLimited

Click here to subscribe to the Orocobre e-Newsletter



These press releases may also interest you

at 15:06
Digital Transformation in the Oil and Gas Industry: Info-Tech Research Group Publishes Digital Strategies to Enhance Sustainability and Production
Within the oil and gas industry, the rapid evolution of market demands, tightening environmental...

at 14:33
Transformative Biotech Welcomes Dr. Barbara Handelin as Co-CEO
Transformative Biotech, LLC (T-Bio), a molecular diagnostics technology company, today announced the appointment of Dr. Barbara Handelin as Co-CEO and to its Board of Directors. Transformative Biotech, LLC is a licensing firm enabling the transition...

at 13:32
Allucent Receives BARDA-Funded Project NextGen Award to Support a COVID-19 Vaccine Decentralized Clinical Trial
Allucent, a global mid-sized clinical research organization (CRO), announced today that it received a project award valued at $25.5 million through the Rapid Response Partnership Vehicle (RRPV) Consortium to conduct its Decentralized Home Focus...

at 12:50
Global Advanced Drug Delivery Systems Market Analysis and Technologies Report 2024-2028 with Johnson & Johnson, Novartis, Roche, Pfizer, Merck & Co., Medtronic and Abbott Dominating - ResearchAndMarkets.com
The "Global Markets and Technologies for Advanced Drug Delivery Systems" report has been added to ResearchAndMarkets.com's offering. The global market for advanced drug delivery systems was valued at $248.2 billion in 2022. The market is expected...

at 12:50
Global Cleanroom Technology Market Report 2024: Historical Market Revenue 2021-2022, Estimates for 2023, and CAGR Projections through 2028 - ResearchAndMarkets.com
The "Global Cleanroom Technology Market 2023-2028" report has been added to ResearchAndMarkets.com's offering. The Global Cleanroom Technology Market was valued at USD 7.5 Billion in 2023 and is expected to reach USD 10.9 Billion, rising at a CAGR...

at 12:26
Progressive Care Inc. Announces Record First Quarter 2024 Revenues of $14.6 Million, an Increase of 28% Over First Quarter 2023 Results
Progressive Care Inc. ("Progressive Care" or the "Company"), a personalized healthcare services and technology provider, today announced financial results for its first quarter ended March 31, 2024. The Company reported record first quarter revenues...

More news about Covid-19 virus...


News published on and distributed by: